Clinical-stage biotech developing a monoclonal antibody to target respiratory disorders.
Industry: Health Care
Latest Trade: ()
First Day Return:
Return from IPO:
Industry: Health Care
IPO Data | |
---|---|
IPO File Date | 09/18/2024 |
Offer Price | |
Price Range n/a | |
Offer Shares (mm) | n/a |
Deal Size ($mm) | $100 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
IPO Data | |
---|---|
IPO Date | |
Offer Price | |
Price Range n/a | |
Offer Shares (mm) | n/a |
Deal Size ($mm) | $100 |
Lock-Up Date | IPO Pro Only |
Street Research | IPO Pro Only |
Underwriters |
---|
J.P. Morgan |
TD Cowen |
more |
Company Data | |
---|---|
Headquarters | Waltham, MA, United States |
Founded | 2021 |
Employees at IPO | 38 |
Website www.upstreambio.com |